Spyre Therapeutics · NASDAQ: SYRE · Biotechnology
Over the past week, Spyre Therapeutics (SYRE) racked up about 8 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 61% bullish but is sharply divided: X runs 100% bullish while Reddit sits at just 33%. Wall Street is more constructive, with 17 of 17 analysts rating SYRE a buy.
There is little buzz around SYRE this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 33% to X at 100%. No other tracker puts the two side by side.
17 analysts have weighed in: a Strong Buy consensus: 17 buy calls against 0 sell, with an average 12-month price target of $101.53.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 39 points above the crowd average of 61%, the professionals are more constructive than retail. The split is inside the crowd: X reads 100% bullish while Reddit sits at 33%, a 67-point spread that single-source trackers miss.
Over the 30-day window, Spyre Therapeutics (SYRE) buzz held subdued around 14.1 while the price drifted up 16.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.9M shares. Updated Jul 13, 2026. Over the last 7 trading days, SYRE gained 10.0%. Buzz activity in the recent week averaged 28.2 and was variable, swinging between 14.1 and 41.4. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 7 of the 10 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for SYRE and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SYRE sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Spyre Therapeutics (SYRE) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 61% bullish across 3 active sources. Those sources contribute 8 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Spyre Therapeutics (SYRE) is fairly quiet with 3 mentions across 2 tracked subreddits. The tone is 33% bullish with stable 3-day activity momentum, suggesting steady attention.
Spyre Therapeutics (SYRE) sentiment is bullish across all 3 tracked sources. X reads 100% bullish, News reads 50% bullish and reddit coverage is the most negative at 33% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
Social sentiment data shows consistently bullish discussion around Spyre Therapeutics (SYRE). All 3 tracked sources lean positive, with reddit being the most bearish at 33% bullish. The buy signal carries 93/100 conviction.
Reddit is the dominant discussion channel with 3 mentions (38% of total volume). X contributes 3 mentions and News contributes 2 mentions. Sentiment is bullish across all sources.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SYRE's buy signal at 93/100 conviction reflects consistently bullish sentiment across multiple platforms. It is a research shortcut, not financial advice.
The SYRE sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Spyre Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry buy signals, pointing to broad bullish pressure rather than an SYRE-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key